Ow RA - Search Results

1

Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).

Palmer JN, Adappa ND, Chandra RK, Davis GE, Mahdavinia M, Messina J, Ow RA, Patel ZM, Peters AT, Sacks H, Schlosser RJ, Sindwani R, Soler ZM, White AA, Wise SK, Mahmoud RA. Palmer JN, et al. Among authors: ow ra. J Allergy Clin Immunol Pract. 2024 Apr;12(4):1049-1061. doi: 10.1016/j.jaip.2023.12.016. Epub 2024 Jan 18. J Allergy Clin Immunol Pract. 2024. PMID: 38244014 Free article. Clinical Trial.

2

The Effect of EDS-FLU on Objective and Patient-Reported Subjective Outcomes for Patients with Chronic Rhinosinusitis with Nasal Polyps.

Ow RA, McGinnis JP 2nd, Sacks HJ, Mehle ME. Ow RA, et al. Ear Nose Throat J. 2022 Apr 18:1455613221088698. doi: 10.1177/01455613221088698. Online ahead of print. Ear Nose Throat J. 2022. PMID: 35437059 Free article.

3

Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.

Ow RA, Soler ZM, Sindwani R, Leopold DA, Lee JT, Mahmoud RA, Han JK. Ow RA, et al. Int Forum Allergy Rhinol. 2023 Jan;13(1):31-41. doi: 10.1002/alr.23043. Epub 2022 Jun 26. Int Forum Allergy Rhinol. 2023. PMID: 35674488 Free PMC article.

4

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587

5

Effect of Radiofrequency Neurolysis on the Symptoms of Chronic Rhinitis: A Randomized Controlled Trial.

Stolovitzky JP, Ow RA, Silvers SL, Bikhazi NB, Johnson CD, Takashima M. Stolovitzky JP, et al. Among authors: ow ra. OTO Open. 2021 Sep 10;5(3):2473974X211041124. doi: 10.1177/2473974X211041124. eCollection 2021 Jul-Sep. OTO Open. 2021. PMID: 34527852 Free PMC article.

6

Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study.

Gevaert P, Saenz R, Corren J, Han JK, Mullol J, Lee SE, Ow RA, Zhao R, Howard M, Wong K, Islam L, Ligueros-Saylan M, Omachi TA, Bachert C. Gevaert P, et al. Among authors: ow ra. J Allergy Clin Immunol. 2022 Mar;149(3):957-965.e3. doi: 10.1016/j.jaci.2021.07.045. Epub 2021 Sep 14. J Allergy Clin Immunol. 2022. PMID: 34530020 Free article. Clinical Trial.

7

Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis.

Ow RA, Shotts S, Kakarlapudi V, McIntyre J, Naclerio RM, You C, Pappas A, Brayton L, Kuang Y, Shao J. Ow RA, et al. Am J Rhinol Allergy. 2022 Nov;36(6):733-740. doi: 10.1177/19458924221107200. Epub 2022 Jun 16. Am J Rhinol Allergy. 2022. PMID: 35708181 Free PMC article. Clinical Trial.

8

Temperature-controlled radiofrequency neurolysis for treatment of chronic rhinitis: 12-month outcomes after treatment in a randomized controlled trial.

Takashima M, Stolovitzky JP, Ow RA, Silvers SL, Bikhazi NB, Johnson CD. Takashima M, et al. Among authors: ow ra. Int Forum Allergy Rhinol. 2023 Feb;13(2):107-115. doi: 10.1002/alr.23047. Epub 2022 Jul 5. Int Forum Allergy Rhinol. 2023. PMID: 35714267 Free PMC article. Clinical Trial.

9

Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.

Fokkens W, Trigg A, Lee SE, Chan RH, Diamant Z, Hopkins C, Howarth P, Lund V, Mayer B, Sousa AR, Yancey S, Tabberer M; SYNAPSE study group. Fokkens W, et al. J Patient Rep Outcomes. 2023 Jan 20;7(1):4. doi: 10.1186/s41687-023-00543-5. J Patient Rep Outcomes. 2023. PMID: 36662344 Free PMC article. Clinical Trial.

10

Temperature-controlled radiofrequency ablation for the treatment of chronic rhinitis: Two-year outcomes from a prospective multicenter trial.

Takashima M, Stolovitzky JP, Ow RA, Silvers SL, McDuffie CM, Dean M, Sedaghat AR, Tajudeen BA. Takashima M, et al. Among authors: ow ra. Int Forum Allergy Rhinol. 2024 Jan 24. doi: 10.1002/alr.23315. Online ahead of print. Int Forum Allergy Rhinol. 2024. PMID: 38266636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page